Document Detail

Intravesical instillation of hyaluronic acid prolonged the effect of bladder hydrodistention in patients with severe interstitial cystitis.
MedLine Citation:
PMID:  20022087     Owner:  NLM     Status:  MEDLINE    
OBJECTIVES: To evaluate the efficacy of intravesical instillation of hyaluronic acid (HA) after hydrodistention for the treatment of patients with interstitial cystitis (IC) having small bladder capacity. METHODS: A total of 47 patients with IC (aged 27-76 years) whose functional bladder capacity was less than 200 mL received bladder hydrodistention. Thereafter, 20 patients received intravesical instillation of 40 mg HA weekly in the first month and then monthly in the following 2 months. Sixteen patients received intravesical heparin instead and 11 patients received hydrodistention alone as the control. Mean voids per day, visual analog scale for pain, and functional bladder capacity were measured before hydrodistention and 3 and 6 months after hydrodistention in all 3 groups and 9 months after hydrodistention in HA and heparin groups. RESULTS: Two patients in the HA group and 1 in the heparin group failed to complete the treatment. Three months after hydrodistention, there was no improvement in the control group. Six and 9 months after hydrodistention, rate of improvement was significantly higher in the HA group than in the heparin group (77.8% vs 33.3%, P < .05; 50% vs 20%, P < .05). At 9 months, heparin treatment did not show any improvement. Improvement in voids per day (-1.8 +/- 2.5, P < .01), visual analog scale (-0.9 +/- 1.1, P < .01), and bladder capacity (16 +/- 18 mL, P < .01) was still significant in the HA group. CONCLUSIONS: Intravesical instillation of HA may obviously prolong the effect of bladder hydrodistention in patients with severe IC. Its effect was better than heparin.
Yuan Shao; Zhou-Jun Shen; Wen-Bin Rui; Wen-Long Zhou
Related Documents :
20535287 - Postnatal outcome of fetal hydronephrosis: implications for prenatal counselling.
19565527 - Biometry of the pubovisceral muscle and levator hiatus assessed by three-dimensional ul...
17587227 - Ileovesicostomy for adults with neurogenic bladders: complications and potential risk f...
15885577 - Long-term complications associated with the indiana pouch urinary diversion in patients...
10599357 - Enalapril (10 mg/day) in systemic sclerosis. one year, double blind, randomised study (...
24950287 - Management of acute appendicitis in ambulatory surgery: is it possible? how to select p...
Publication Detail:
Type:  Controlled Clinical Trial; Journal Article    
Journal Detail:
Title:  Urology     Volume:  75     ISSN:  1527-9995     ISO Abbreviation:  Urology     Publication Date:  2010 Mar 
Date Detail:
Created Date:  2010-03-09     Completed Date:  2010-04-05     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0366151     Medline TA:  Urology     Country:  United States    
Other Details:
Languages:  eng     Pagination:  547-50     Citation Subset:  IM    
Copyright Information:
2010 Elsevier Inc. All rights reserved.
Department of Urology, Ruijin Hospital School of Medicine, Shanghai Jiao Tong University, Shanghai, People's Republic of China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Administration, Intravesical
Combined Modality Therapy
Cystitis, Interstitial / physiopathology*,  therapy*
Hyaluronic Acid / administration & dosage*
Middle Aged
Prospective Studies
Severity of Illness Index
Reg. No./Substance:
7732-18-5/Water; 9004-61-9/Hyaluronic Acid
Comment In:
Urology. 2010 Mar;75(3):550-1; author reply 551   [PMID:  20211366 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Effects of combined use of trospium chloride and melatonin on in vitro contractility of rat urinary ...
Next Document:  Persistent M??llerian Duct Syndrome With Torsion of a Transverse Testicular Ectopia: First Reported ...